Related Experiment Videos

Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding

Attaya Suvannasankha1, Rafat Abonour, Oscar W Cummings

  • 1Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis 46202, USA. asuvanna@iupui.edu

Clinical Lymphoma & Myeloma
|October 16, 2008
PubMed

Insights

Gastrointestinal bleeding is an uncommon complication of multiple myeloma (MM). This case highlights plasmacytoma as a cause of persistent GI bleeding in MM patients, emphasizing the need for increased clinical awareness.

Area of Science:

  • Hematology
  • Gastroenterology
  • Oncology

Background:

  • Multiple myeloma (MM) is a hematologic malignancy characterized by plasma cell proliferation.
  • Gastrointestinal (GI) involvement in MM is rare, with limited reported cases.
  • Understanding rare complications is crucial for comprehensive patient management.

Observation:

  • A patient with a known diagnosis of multiple myeloma presented with upper GI bleeding.
  • The GI bleeding was persistent and refractory to standard medical and endoscopic therapies.
  • A solitary plasmacytoma was identified as the cause of the bleeding.

Findings:

  • Plasmacytoma can manifest as a cause of significant GI bleeding in MM patients.
  • Abnormal hemostasis, involving the coagulation cascade, contributes to bleeding risk in MM.
  • This case underscores the importance of considering extramedullary plasmacytoma in MM with unexplained GI hemorrhage.

Implications:

  • Heightened awareness of plasmacytoma as a cause of GI bleeding in MM is warranted.
  • Clinicians should consider GI plasmacytoma in MM patients with refractory GI bleeding.
  • Further research into the mechanisms of GI involvement and bleeding in MM may improve diagnostic and therapeutic strategies.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...